Free Trial!
Today’s Best Stocks To Trade! Click Here
Now you can by using the ONLY FREE LIVE CHAT available on the internet dedicated to stock symbols.
Now you can by using Stockwire LIVE CHAT. Stockwire LIVE CHAT is the only FREE chat room service on the internet with chat rooms dedicated to stock symbols.
If you can't find a chat room for your favorite stock, just shoot us an email at chat@stockwire.com requesting it and we will create it immediately.
Stockwire LIVE CHAT is changing how investors interact with each other and we are glad to be the ones bringing it to you FREE of charge!
Visit Stockwire.com and click the "Chat Live" button at the top to begin chatting with your fellow shareholders!
----------------------------------------------------------
To enter the ARGA chat room, visit the following link: http://www.stockwire.com/livechat
Auriga Laboratories, Inc. (OTCBB: ARGA | news | PowerRating | PR Charts ) (Tue, January 8th, 2008, 8:45am ET) Auriga Laboratories, Inc., a specialty pharmaceutical company, announced today the signing of a co-promotion agreement with MiddleBrook Pharmaceuticals, Inc., pursuant to which Auriga will co-promote Keflex 750 mg capsules (cephalexin capsules, USP), to Primary Care Specialists in the U.S.
Cephalexin, the generic form of Keflex, is the third most prescribed outpatient antibiotic in the U.S., with approximately 25 million prescriptions written annually. Cephalexin is the number-one most prescribed oral cephalosporin antibiotic and is also the number-one recommended oral antibiotic therapy for uncomplicated skin and skin structure infections.
The co-promotion will begin during the 1st Quarter of 2008. "This agreement solidifies Auriga's commitment to enhance our product portfolio. Currently, over 50% of cephalexin prescriptions are written by Primary Care Specialists which makes Keflex 750 mg a highly synergistic addition to Auriga's current primary care promotional efforts," said Philip S. Pesin, CEO of Auriga.
Aurelio Resource Corporation (OTCBB: AULO - http://finance.yahoo.com/q?s=AULO.OB ) (Tue, January 8th, 2008, 6:00am ET) Aurelio Resource Corporation is pleased to announce gold assay results from recent drilling in the MAN Area of the Company's wholly owned Hill Copper-Zinc Project, located in the Turquoise Mining District, Cochise County, Arizona.
The fire assay results reported in Table 1 correspond to previously-released copper, zinc, and silver assay information for drill holes BR07-24 and -26 (see November 8, 2007 news release).
Drill hole BR07-25 was assayed for gold between the depths of 235 and 450 feet to determine the gold content of a previously-reported copper/zinc/silver assay interval (175 feet at 1.45% copper, 0.45% zinc and 1.8 parts-per-million (ppm) silver, including 100 ft averaging 2.29% copper, 0.11% zinc and 1.8 ppm silver). Gold assay results were 125 parts-per-billion (ppb) and 160 ppb, respectively, over these intervals. The strongest gold intercept came below this interval, with an average of 188 ppb between 410 feet and 450 feet.
Gold assays for holes BR07-27 and BR07-28 are pending.
The results indicate the presence of significant gold mineralization at the MAN Area.
The Company's geologists believe that there are probably multiple phases of gold deposition at the Hill project. Establishing the distribution and nature of the gold mineralization will be a primary focus of the next drilling program, scheduled for the first quarter of 2008.
----------------------------------------------------------
To enter the TCPS chat room, visit the following link: http://www.stockwire.com/livechat
Terocelo, Inc. (OTCBB: TCPS | news | PowerRating | PR Charts ) (Tue, January 8th, 2008, 11:14am ET) Terocelo, Inc. previously announced it had entered into a Memorandum of Understanding for the creation of a strategic alliance based on its Lycon(tm) chip and proprietary True Software Radio(r) (TSR) with a multibillion dollar Asian Technology fund. This transaction has not yet closed, but critical hurdles have been cleared and the Company is to meet with the fund's executives next week in what is believed to be a final step toward consummation of the definitive agreement. The definitive agreement will then be submitted for Board of Director and shareholder approval.
Under the terms of the agreement, the fund will pay thirty million dollars ($30,000,000) and continuing royalties to Terocelo in exchange for certain exclusive license rights to the Company's TSR technology. In addition, the fund will provide twenty million dollars ($20,000,000) to establish and fund an independent corporate entity, in which Terocelo will have an equity interest, to initiate Asian operations to develop applications and promote the sales of products containing the TSR technology. These funds will cover on-going costs for foundry services, design center operations, application staging, as well as marketing and sales efforts.
The ability to access these additional financial and human resources should allow the Company to secure pending product development contracts with industry leading corporations that are interested in incorporating TSR technology into their product lines. Most importantly, it will provide a solid financial base for the extended future of Terocelo.
Prior to the completion of the Definitive Agreement, the Chinese business group is in the process of delivering a series of bridge financing instruments, which it is anticipated will provide sufficient working capital to stabilize the Company's operations and allow its engineering efforts to continue to develop the products for market.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com.
About Stockwire: Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm.
CONTACT: The Stockwire Group Tel: +1 512 358 8440 e-mail: info@stockwire.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
